Tag: Richard Owens

OTTAWA, ON (June 2, 2020): Changes to the Patented Medicine Prices Review Board (PMPRB) have been delayed until January 2021 ...

Now more than ever, we should want drug companies to be able to charge high prices, writes Richard Owens in ...

Universities have relied on 'fair dealing' provisions to photocopy mountains of material and distribute them to students, writes Richard Owens.  ...

The internet is far better off with authoritative, factual sources of reference, such as are provided by professional, fact-checking newspapers. ...

Increased drug revenues enable increased research and development expenditures, which in turn result in better health and longer lives, writes ...

Current innovation policies are a mess of disparate and expensive programs that dole out vast amounts of money wastefully and inefficiently, ...

On a grander scale there is much to be grateful for from 2019. Hope and revolution are in the air, ...

GoldTV is one of a species of IP thieves that take advantage of the internet’s anonymity and reach, writes Richard ...

We need a whole new direction on innovation. Let’s wind up all the innovation corporate welfare programs and return their ...

OTTAWA, ON (October 11, 2019): Canada lags behind other developed nations when it comes to innovation. From declining investments in ...

Price-focused regulatory changes could limit access to new drugs and dampen R&D investment, writes Richard Owens. By Richard C. Owens, ...

MLI Munk Senior Fellow Richard Owens recently contributed, alongside co-authors Daniel Schwanen (C.D. Howe Institute) and Stephen Ezell (Information Technology ...